Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery systemGiuseppe Francesco Sferrazza Papa, Aldo E. Calogero, Sandro La Vignera et al.|Diabetes Research and Clinical Practice|2025Cited by 4
Impact of automated insulin delivery (AID) systems on quality of life (QoL): Validation of the AID-QoL questionnaireGiuseppe Francesco Sferrazza Papa, Aldo E. Calogero, Rossella Cannarella et al.|Journal of Diabetes and its Complications|2025Cited by 2
The Automatic Correction Boluses in an Advanced Hybrid Closed-Loop System: Algorithm Performance and Clinical ImplicationsGiuseppe Papa, Aldo E. Calogero, Rossella Cannarella et al.|Journal of Diabetes Science and Technology|2026Cited by 1
Transitioning to Omnipod 5®: Effectiveness, Safety, and Patient-Reported Outcomes of a Tubeless Automated Insulin Delivery System in Adults with Type 1 Diabetes MellitusCarmelo Gusmano, Giuseppe Papa, Rossella Cannarella et al.|Biomedicines|2026Cited by 0
Effect of Active Insulin Time and Glycemic Targets on Automatic Correction Bolus DeliveryGiuseppe Papa, Aldo E. Calogero, Rossella Cannarella et al.|Journal of Diabetes Science and Technology|2026Cited by 0